Wells Fargo’s Anixa Biosciences ANIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$34.7K Buy
10,500
+2,000
+24% +$6.6K ﹤0.01% 5207
2025
Q1
$24.3K Hold
8,500
﹤0.01% 5190
2024
Q4
$19.7K Hold
8,500
﹤0.01% 5276
2024
Q3
$26.8K Hold
8,500
﹤0.01% 5153
2024
Q2
$18.8K Buy
8,500
+7,752
+1,036% +$17.1K ﹤0.01% 5230
2024
Q1
$2.33K Buy
748
+9
+1% +$28 ﹤0.01% 5610
2023
Q4
$2.87K Buy
739
+13
+2% +$50 ﹤0.01% 5595
2023
Q3
$2.37K Buy
726
+3
+0.4% +$10 ﹤0.01% 5694
2023
Q2
$2.31K Buy
723
+9
+1% +$29 ﹤0.01% 5882
2023
Q1
$3.07K Sell
714
-995
-58% -$4.28K ﹤0.01% 5841
2022
Q4
$7.26K Buy
1,709
+1,007
+143% +$4.28K ﹤0.01% 5344
2022
Q3
$3K Hold
702
﹤0.01% 5690
2022
Q2
$3K Buy
702
+17
+2% +$73 ﹤0.01% 5855
2022
Q1
$2K Buy
685
+1
+0.1% +$3 ﹤0.01% 6288
2021
Q4
$2K Sell
684
-5,501
-89% -$16.1K ﹤0.01% 6300
2021
Q3
$30K Sell
6,185
-5
-0.1% -$24 ﹤0.01% 5503
2021
Q2
$24K Buy
6,190
+31
+0.5% +$120 ﹤0.01% 5497
2021
Q1
$29K Buy
6,159
+5,013
+437% +$23.6K ﹤0.01% 5685
2020
Q4
$3K Sell
1,146
-6,040
-84% -$15.8K ﹤0.01% 5909
2020
Q3
$17K Sell
7,186
-778
-10% -$1.84K ﹤0.01% 5493
2020
Q2
$24K Sell
7,964
-119
-1% -$359 ﹤0.01% 5358
2020
Q1
$13K Buy
8,083
+113
+1% +$182 ﹤0.01% 5413
2019
Q4
$26K Sell
7,970
-100
-1% -$326 ﹤0.01% 5398
2019
Q3
$33K Hold
8,070
﹤0.01% 5359
2019
Q2
$29K Buy
8,070
+1,100
+16% +$3.95K ﹤0.01% 5370
2019
Q1
$32K Sell
6,970
-201
-3% -$923 ﹤0.01% 5315
2018
Q4
$29K Sell
7,171
-250
-3% -$1.01K ﹤0.01% 5356
2018
Q3
$35K Buy
7,421
+6,520
+724% +$30.8K ﹤0.01% 5385
2018
Q2
$3K Hold
901
﹤0.01% 5746
2018
Q1
$4K Hold
901
﹤0.01% 5670
2017
Q4
$2K Hold
901
﹤0.01% 5732
2017
Q3
$2K Sell
901
-1,616
-64% -$3.59K ﹤0.01% 5725
2017
Q2
$3K Hold
2,517
﹤0.01% 5617
2017
Q1
$8K Buy
2,517
+1,866
+287% +$5.93K ﹤0.01% 5517
2016
Q4
$4K Hold
651
﹤0.01% 5605
2016
Q3
$3K Buy
651
+151
+30% +$696 ﹤0.01% 5641
2016
Q2
$2K Hold
500
﹤0.01% 5620
2016
Q1
$2K Hold
500
﹤0.01% 5744
2015
Q4
$2K Hold
500
﹤0.01% 5699
2015
Q3
$2K Buy
+500
New +$2K ﹤0.01% 5676